Viveve Medical, Inc. (VIVE): Price and Financial Metrics


Viveve Medical, Inc. (VIVE): $2.98

0.14 (+4.93%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

VIVE Stock Summary

  • VIVE has a market capitalization of $29,370,473 -- more than approximately merely 6.44% of US stocks.
  • In terms of volatility of its share price, VIVE is more volatile than 97.67% of stocks we're observing.
  • Viveve Medical Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -34.36%, greater than the shareholder yield of only 7.61% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Viveve Medical Inc, a group of peers worth examining would be YELP, MGNI, TENB, ASPN, and DOMO.
  • VIVE's SEC filings can be seen here. And to visit Viveve Medical Inc's official web site, go to www.viveve.com.

VIVE Stock Price Chart Interactive Chart >

Price chart for VIVE

VIVE Price/Volume Stats

Current price $2.98 52-week high $14.40
Prev. close $2.84 52-week low $2.43
Day low $2.81 Volume 156,000
Day high $2.98 Avg. volume 1,866,924
50-day MA $3.34 Dividend yield N/A
200-day MA $4.68 Market Cap 30.82M

Viveve Medical, Inc. (VIVE) Company Bio


Viveve Medical, Inc. designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal laxity. The company was founded in 2005 and is based in Sunnyvale, California.


VIVE Latest News Stream


Event/Time News Detail
Loading, please wait...

VIVE Latest Social Stream


Loading social stream, please wait...

View Full VIVE Social Stream

Latest VIVE News From Around the Web

Below are the latest news stories about Viveve Medical Inc that investors may wish to consider to help them evaluate VIVE as an investment opportunity.

Viveve Reports Full Year 2020 Financial Results and Provides Corporate Update - Stocks News Feed

Company continuing to advance its U.S. pivotal PURSUIT trial in stress urinary incontinence Conference call to be hosted by Company at 5:00 PM ET today ENGLEWOOD, CO / ACCESSWIRE / March 18, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women’s intimate health, today reported financial results for the year ended… Read More »Viveve Reports Full Year 2020 Financial Results and Provides Corporate Update

Stocks News Feed | March 18, 2021

Viveve Reports Full Year 2020 Financial Results and Provides Corporate Update

Company continuing to advance its U. pivotal PURSUIT trial in stress urinary incontinence Conference call to be hosted by Company at 5:00 PM ET todayENGLEWOOD, CO / ACCESSWIRE / March 18, 2021 / Viveve Medical, Inc.

Yahoo | March 18, 2021

Viveve Medical, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 18, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 18, 2021 at 5:00 PM Eastern Time.

Yahoo | March 18, 2021

The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 4) AtriCure, Inc. (NASDAQ: ATRC ) Five Prime Therapeutics, Inc. ( NASDAQ: FPRX) - announced a deal to be bought by Amgen Inc. (NASDAQ: AMGN ) for $1.9 billion Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 4) AbCellera Biologics Inc. (NASDAQ: ABCL ) Acutus Medical, Inc. (NASDAQ: AFIB ) ADC Therapeutics SA (NYSE: ADCT ) Aptose Biosciences Inc. (NASDAQ: APTO ) Assembly Biosciences, Inc. (NASDAQ: ASMB ) Athenex, Inc. (NASDAQ: ATNX ) Biophytis SA (NASDAQ: BPTS ) Bioventus Inc. (NASDAQ: BVS ) Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI ) BriaCell Therapeutics Corp. (NASDAQ: BCTX ) Decibel Therapeutics, Inc. (NASDAQ: DBTX ) Dyne Ther...

Benzinga | March 5, 2021

Viveve to Participate in the H.C. Wainwright Global Life Sciences Virtual Conference

ENGLEWOOD, CO / ACCESSWIRE / March 2, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive officer, will participate in the virtual H.

Yahoo | March 2, 2021

Read More 'VIVE' Stories Here

VIVE Price Returns

1-mo 0.00%
3-mo -13.12%
6-mo -44.79%
1-year -46.31%
3-year -99.90%
5-year N/A
YTD -36.60%
2020 -62.70%
2019 -98.80%
2018 -78.87%
2017 -3.50%
2016 N/A

Continue Researching VIVE

Want to see what other sources are saying about Viveve Medical Inc's financials and stock price? Try the links below:

Viveve Medical Inc (VIVE) Stock Price | Nasdaq
Viveve Medical Inc (VIVE) Stock Quote, History and News - Yahoo Finance
Viveve Medical Inc (VIVE) Stock Price and Basic Information | MarketWatch

Page generated in 1.0666 seconds.